Bank of New York Mellon’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $37.4M | Sell |
|
|||||
|
2025
Q2 | $32.8M | Sell |
|
|||||
|
2025
Q1 | $49.4M | Sell |
|
|||||
|
2024
Q4 | $87.8M | Sell |
|
|||||
|
2024
Q3 | $90.1M | Buy |
|
|||||
|
2024
Q2 | $53.8M | Buy |
|
|||||
|
2024
Q1 | $53.7M | Buy |
|
|||||
|
2023
Q4 | $43.2M | Sell |
|
|||||
|
2023
Q3 | $50.3M | Sell |
|
|||||
|
2023
Q2 | $56M | Sell |
|
|||||
|
2023
Q1 | $77.4M | Sell |
|
|||||
|
2022
Q4 | $70M | Sell |
|
|||||
|
2022
Q3 | $78.7M | Sell |
|
|||||
|
2022
Q2 | $97.4M | Buy |
|
|||||
|
2022
Q1 | $109M | Sell |
|
|||||
|
2021
Q4 | $149M | Sell |
|
|||||
|
2021
Q3 | $151M | Sell |
|
|||||
|
2021
Q2 | $157M | Buy |
|
|||||
|
2021
Q1 | $102M | Sell |
|
|||||
|
2020
Q4 | $106M | Sell |
|
|||||
|
2020
Q3 | $96.6M | Buy |
|
|||||
|
2020
Q2 | $82.1M | Sell |
|
|||||
|
2020
Q1 | $87.1M | Buy |
|
|||||
|
2019
Q4 | $91.4M | Sell |
|
|||||
|
2019
Q3 | $86.4M | Sell |
|
|||||
|
2019
Q2 | $83.7M | Sell |
|
|||||
|
2019
Q1 | $85.9M | Buy |
|
|||||
|
2018
Q4 | $62.9M | Buy |
|
|||||
|
2018
Q3 | $72.4M | Buy |
|
|||||
|
2018
Q2 | $62.6M | Sell |
|
|||||
|
2018
Q1 | $55M | Sell |
|
|||||
|
2017
Q4 | $52.5M | Sell |
|
|||||
|
2017
Q3 | $54.1M | Sell |
|
|||||
|
2017
Q2 | $56.3M | Buy |
|
|||||
|
2017
Q1 | $48.8M | Buy |
|
|||||
|
2016
Q4 | $41.8M | Buy |
|
|||||
|
2016
Q3 | $36.3M | Buy |
|
|||||
|
2016
Q2 | $31.3M | Sell |
|
|||||
|
2016
Q1 | $30.5M | Sell |
|
|||||
|
2015
Q4 | $31M | Sell |
|
|||||
|
2015
Q3 | $30.8M | Buy |
|
|||||
|
2015
Q2 | $34M | Sell |
|
|||||
|
2015
Q1 | $30.8M | Buy |
|
|||||
|
2014
Q4 | $23.9M | Sell |
|
|||||
|
2014
Q3 | $23.1M | Buy |
|
|||||
|
2014
Q2 | $24M | Sell |
|
|||||
|
2014
Q1 | $26M | Sell |
|
|||||
|
2013
Q4 | $27.6M | Buy |
|
|||||
|
2013
Q3 | $24.6M | Buy |
|
|||||
|
2013
Q2 | $23.3M | Buy |
|